Clinical Trial Update: Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating amprenavir/ritonavir or saquinavir/ritonavir in HIV-infected subjects after failure of Kaletra as their second prote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Amprenavir (amprenavir)
• Ritonavir (Ritonavir)
• Saquinavir (saquinavir)

Snippet

Sponsor: Abbott | Conditions: HIV Infections | Phase 2, Phase 3 | Status: COMPLETED